Literature DB >> 13593927

Corneal epithelial changes occurring during chloroquine (aralen) therapy.

L L CALKINS.   

Abstract

Entities:  

Keywords:  CHLOROQUINE/injurious effects; CORNEA/effect of drugs on

Mesh:

Substances:

Year:  1958        PMID: 13593927     DOI: 10.1001/archopht.1958.00940081001001

Source DB:  PubMed          Journal:  AMA Arch Ophthalmol        ISSN: 0096-6339


× No keyword cloud information.
  12 in total

1.  Ocular complications induced by chloroquine therapy.

Authors:  S GOLDEN; N VAN DONGE
Journal:  Calif Med       Date:  1963-06

2.  Synthetic antimalarial drug therapy in lupus erythematosus and polymorphous light eruptions.

Authors:  J H EPSTEIN
Journal:  Calif Med       Date:  1960-02

3.  RETINOPATHY DURING CHLOROQUINE THERAPY.

Authors:  W Wilson
Journal:  Br J Ophthalmol       Date:  1961-11       Impact factor: 4.638

4.  OCULAR LESIONS AFTER TREATMENT WITH CHLOROQUINE.

Authors:  H E Hobbs; S P Eadie; F Somerville
Journal:  Br J Ophthalmol       Date:  1961-04       Impact factor: 4.638

5.  Ocular Complications of Treatment with Chloroquine and Related Antimalarial Drugs.

Authors: 
Journal:  Can Med Assoc J       Date:  1963-03-09       Impact factor: 8.262

6.  [On the etiology of dystrophia corneae verticillata].

Authors:  A Denden
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1966-04-18

7.  Electro-oculogram findings in patients treated with antimalarial drugs.

Authors:  H Kolb
Journal:  Br J Ophthalmol       Date:  1965-11       Impact factor: 4.638

8.  Chloroquine myopathy.

Authors:  M J Eadie; T M Ferrier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1966-08       Impact factor: 10.154

9.  Drug-induced lipidoses of the cornea and conjunctiva.

Authors:  D J D'Amico; K R Kenyon
Journal:  Int Ophthalmol       Date:  1981-08       Impact factor: 2.031

10.  X-chromosomal-linked diseases affecting the eye: status of the heterozygote female.

Authors:  A E Krill
Journal:  Trans Am Ophthalmol Soc       Date:  1969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.